We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bristol-Myers Squibb Says Probe Clears It of Illegal Conduct in Plavix Deal
Bristol-Myers Squibb Says Probe Clears It of Illegal Conduct in Plavix Deal
August 18, 2006
The board of directors of Bristol-Myers Squibb (BMS) announced that an internal probe has unearthed no evidence the company engaged in illegal conduct while it and sanofi-aventis negotiated a patent settlement with Apotex over their blockbuster blood thinner Plavix.